COvera in BRAnch Registry

NCT04598802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-11-14

No results posted yet for this study

Summary

The purpose of the registry is to evaluate the peri-operative and short-, mid- and long-term outcomes of the Bard Covera Plus (Tempe, Arizona, USA) for the treatment of atherosclerotic aorto-iliac aneurysm in combination with a multibranched endograft

Conditions

  • Aneurysm

Interventions

DEVICE

covered stent

atherosclerotic aorto-iliac aneurysm

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-16
Primary Completion
2022-10-30
Completion
2022-10-30

Countries

  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04598802 on ClinicalTrials.gov